References

Risk factors for canine osteoarthritis and its predisposing arthropathies: A systemic review

10.3389/fvets.2020.00220 · 2020 · External reference

Strategies and challenges for the next generation of therapeutic antibodies

10.1038/nri2747 · 2010 · External reference

The canine orthopedic index. Step 1: devising the items

10.1111/j.1532-950x.2014.12142.x · 2014 · External reference

The canine orthopedic index. Step 2: psychometric testing

10.1111/j.1532-950x.2014.12141.x · 2014 · External reference

Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis

10.2460/ajvr.68.6.631 · 2007 · External reference

Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis

10.2460/javma.233.8.1278 · 2008 · External reference

The canine orthopedic index. Step 3: responsiveness testing

10.1111/j.1532-950x.2014.12162.x · 2014 · External reference

Unresolved reference

2017 · External reference

Power of treatment success definitions when the canine brief pain inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis

10.2460/ajvr.74.12.1467 · 2013 · External reference

Non-steroidal anti-inflammatory drugs in the pharmacological management of osteoarthritis in the very old: Prescribe or proscribe?

10.1177/1759720x211022149 · 2021 · External reference

The number needed to treat: A clinically useful measure of treatment effect

10.1136/bmj.310.6977.452 · 1995 · External reference

A prospective, randomized, blinded, placebo-controlled multisite clinical study of bedinvetmab, a canine monoclonal antibody targeting nerve growth factor, in dogs with osteoarthritis

10.1016/j.vaa.2021.08.001 · 2021 · External reference

Unresolved reference

External reference

Unresolved reference

External reference

Regression to the mean: Statistical bias can mislead interpretation in cartilage and osteoarthritis clinics and research

10.1177/19476035241293048 · 2024 · External reference

Prevalence of radiographic appendicular osteoarthritis and associated clinical signs in young dogs

10.1038/s41598-024-52324-9 · 2024 · External reference

A noninferiority trial evaluating the efficacy of bedinvetmab compared to grapiprant for osteoarthritis-pain in dogs using force plate gait analysis

10.1038/s41598-026-37626-4 · 2026 · External reference

The present state of the art in expression, production and characterization of monoclonal antibodies

10.1007/s11030-015-9625-z · 2015 · External reference

Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats

10.1111/jvim.16291 · 2021 · External reference

Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis

10.1111/j.1748-5827.2009.00765.x · 2009 · External reference

Psychometric testing of the Helsinki chronic pain index by completion of a questionnaire in Finnish by owners of dogs with chronic signs of pain caused by osteoarthritis

10.2460/ajvr.70.6.727 · 2009 · External reference

A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

10.3389/fvets.2025.1502218 · 2025 · External reference

Osteoarthritis. Joint anatomy, physiology, and pathobiology

10.1016/s0195-5616(97)50076-3 · 1997 · External reference

Nonsurgical management of osteoarthritis in dogs

10.1016/j.cvsm.2008.08.001 · 2008 · External reference

Laboratory safety evaluation of bedinvetmab, a canine anti-nerve growth factor monoclonal antibody, in dogs

10.1016/j.tvjl.2021.105733 · 2021 · External reference

Spontaneous dog osteoarthritis – a One Medicine vision

10.1038/s41584-019-0202-1 · 2019 · External reference

A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis

10.1111/vde.12376 · 2016 · External reference

A blinded, randomized, placebo-controlled trial of the safety of lokivetmab (ZTS-00103289), a caninized anti-canine IL-31 monoclonal antibody in client-owned dogs with atopic dermatitis

10.1111/vde.12364 · 2016 · External reference

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody

10.1016/j.vaa.2023.06.003 · 2023 · External reference

Evaluation of clinical metrology instrument in dogs with osteoarthritis

10.1111/jvim.13923 · 2016 · External reference

A prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an EP4 prostaglandin receptor antagonist (PRA), in dogs with osteoarthritis

10.1111/jvim.13948 · 2016 · External reference

Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis

10.1186/1746-6148-8-162 · 2012 · External reference

Clinical assessment of osteoarthritis pain: Contemporary scenario, challenges, and future perspectives

10.1007/s40122-024-00592-8 · 2024 · External reference

Unresolved reference

2019 · External reference

Evaluation of construct and criterion validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) clinical metrology instrument and comparison to two other instruments

10.1371/journal.pone.0058125 · 2013 · External reference

Linguistic validation of the canine brief pain inventory (CBPI) for global use

10.3389/fvets.2021.769112 · 2021 · External reference

Identification of canine osteoarthritis using an owner-reported questionnaire and treatment monitoring using functional mobility tests

10.1111/jsap.13500 · 2022 · External reference